KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Income from Continuing Operations (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Income from Continuing Operations data on record, last reported at 64200000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 81.39% year-over-year to 64200000.0; the TTM value through Dec 2025 reached 1056000000.0, down 24.36%, while the annual FY2025 figure was 1056000000.0, 24.36% down from the prior year.
  • Income from Continuing Operations reached 64200000.0 in Q4 2025 per EW's latest filing, down from 292300000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 489500000.0 in Q2 2021 and bottomed at 64200000.0 in Q4 2025.
  • Average Income from Continuing Operations over 5 years is 325100000.0, with a median of 339150000.0 recorded in 2021.
  • Peak YoY movement for Income from Continuing Operations: skyrocketed 501.56% in 2021, then tumbled 81.39% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 335300000.0 in 2021, then plummeted by 40.2% to 200500000.0 in 2022, then grew by 20.7% to 242000000.0 in 2023, then surged by 42.56% to 345000000.0 in 2024, then crashed by 81.39% to 64200000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 64200000.0 in Q4 2025, 292300000.0 in Q3 2025, and 335900000.0 in Q2 2025.